Literature DB >> 10882398

On the regulation of ischaemia-induced glutamate efflux from rat cortex by GABA; in vitro studies with GABA, clomethiazole and pentobarbitone.

R M Nelson1, A R Green, D G Lambert, A H Hainsworth.   

Abstract

Prisms of adult rat cortex were maintained in vitro in either aerobic conditions (control) or conditions simulating an acute ischaemic challenge (hypoxia with no added glucose). Endogenous glutamate efflux increased with time in ischaemic conditions, being 2.7 fold higher than control efflux at 45 min. Returning prisms to control solution after 20 min of simulated ischaemia resulted in glutamate efflux returning to near-control values. Endogenous GABA efflux in ischaemic conditions also increased, being 4.5 fold higher than control efflux at 45 min. Ischaemia-induced glutamate efflux was not accompanied by increased lactate dehydrogenase efflux and was unaltered by omitting calcium from the extra-cellular solution and adding EGTA (0.1 mM). Both GABA and the GABA-mimetic clomethiazole inhibited ischaemia-induced glutamate efflux, with IC(50) values of 26 and 24 microM respectively. The maximum inhibition by either drug was 60 - 70%. Bicuculline (10 microM) abolished the inhibitory effect of GABA (100 microM) but not clomethiazole (100 microM). Picrotoxin (100 microM) abolished the action of both GABA and clomethiazole. Pentobarbitone inhibited glutamate efflux at 100 - 300 microM (maximal inhibition: 39%). Bicuculline (10 microM) abolished this effect. These data suggest that ischaemia-induced glutamate efflux from rat cerebral cortex is calcium-independent and not due to cell damage up to 45 min. The inhibitory effect of GABA, clomethiazole and pentobarbitone on ischaemia-induced glutamate efflux appears to be mediated by GABA(A) receptors. The results suggest that clomethiazole, unlike pentobarbitone, is able to activate the GABAA receptor-linked chloride channel directly and not merely potentiate the effect of endogenous GABA.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10882398      PMCID: PMC1572159          DOI: 10.1038/sj.bjp.0703398

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  46 in total

Review 1.  Rodent models of cerebral ischemia.

Authors:  M D Ginsberg; R Busto
Journal:  Stroke       Date:  1989-12       Impact factor: 7.914

Review 2.  Protection against ischaemic neuronal damage by drugs acting on excitatory neurotransmission.

Authors:  B Meldrum
Journal:  Cerebrovasc Brain Metab Rev       Date:  1990

3.  Attenuation by chlormethiazole administration of the rise in extracellular amino acids following focal ischaemia in the cerebral cortex of the rat.

Authors:  H A Baldwin; J L Williams; M Snares; T Ferreira; A J Cross; A R Green
Journal:  Br J Pharmacol       Date:  1994-05       Impact factor: 8.739

4.  The protective action of chlormethiazole against ischaemia-induced neurodegeneration in gerbils when infused at doses having little sedative or anticonvulsant activity.

Authors:  A J Cross; J A Jones; M Snares; K G Jostell; U Bredberg; A R Green
Journal:  Br J Pharmacol       Date:  1995-04       Impact factor: 8.739

5.  GABA agonist "muscimol" is neuroprotective in repetitive transient forebrain ischemia in gerbils.

Authors:  A Shuaib; R Mazagri; S Ijaz
Journal:  Exp Neurol       Date:  1993-10       Impact factor: 5.330

6.  The human neuroblastoma cell line, IMR-32 possesses a GABAA receptor lacking the benzodiazepine modulatory site.

Authors:  S M Anderson; R J De Souza; A J Cross
Journal:  Neuropharmacology       Date:  1993-05       Impact factor: 5.250

7.  Coupling among energy failure, loss of ion homeostasis, and phospholipase A2 and C activation during ischemia.

Authors:  K Katsura; E B Rodriguez de Turco; J Folbergrová; N G Bazan; B K Siesjö
Journal:  J Neurochem       Date:  1993-11       Impact factor: 5.372

8.  The immediate consequences of middle cerebral artery occlusion on GABA synthesis in mouse cortex and cerebellum.

Authors:  A R Green; A J Cross; M F Snape; R J De Souza
Journal:  Neurosci Lett       Date:  1992-04-13       Impact factor: 3.046

9.  Modulation of GABAA and glycine receptors by chlormethiazole.

Authors:  T G Hales; J J Lambert
Journal:  Eur J Pharmacol       Date:  1992-01-21       Impact factor: 4.432

Review 10.  Triggering and execution of neuronal death in brain ischaemia: two phases of glutamate release by different mechanisms.

Authors:  M Szatkowski; D Attwell
Journal:  Trends Neurosci       Date:  1994-09       Impact factor: 13.837

View more
  5 in total

Review 1.  Gamma aminobutyric acid (GABA) receptor agonists for acute stroke.

Authors:  Jia Liu; Lu-Ning Wang; Xin Ma; Xunming Ji
Journal:  Cochrane Database Syst Rev       Date:  2016-10-04

2.  Alleviation of glutamate mediated neuronal insult by piroxicam in rodent model of focal cerebral ischemia: a possible mechanism of GABA agonism.

Authors:  Pallab Bhattacharya; Anand Kumar Pandey; Sudip Paul; Ranjana Patnaik
Journal:  J Physiol Biochem       Date:  2014-10-08       Impact factor: 5.080

3.  Preadmission use of benzodiazepines and stroke outcomes: the Biostroke prospective cohort study.

Authors:  Olivier Colin; Julien Labreuche; Julie Deguil; Anne-Marie Mendyk; Valérie Deken; Charlotte Cordonnier; Dominique Deplanque; Didier Leys; Régis Bordet
Journal:  BMJ Open       Date:  2019-01-15       Impact factor: 2.692

4.  Gamma aminobutyric acid (GABA) receptor agonists for acute stroke.

Authors:  Jia Liu; Jing Zhang; Lu-Ning Wang
Journal:  Cochrane Database Syst Rev       Date:  2018-10-30

5.  Effects of Dizocilpine, Midazolam and Their Co-Application on the Trimethyltin (TMT)-Induced Rat Model of Cognitive Deficit.

Authors:  Marketa Chvojkova; Hana Kubova; Karel Vales
Journal:  Brain Sci       Date:  2021-03-22
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.